In silico immunogenicity assessment for sequences containing unnatural amino acids: A method using existing in silico algorithm infrastructure and a vision for future enhancements by Riley Nolan | Oct 11, 2022
Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease by Riley Nolan | Jun 22, 2021
Modulation of B. pseudomallei Immune Responses by Human-like T Cell Epitopes by Annie De Groot | Nov 20, 2019Modulation of B. pseudomallei Immune Responses by Human-like T Cell Epitopes
Innovative Preclinical Assessment Tools for Safety and Efficacy of Protein and Peptide Therapeutics … Of Peptides and P-ANDAS A Case Study of Taspoglutide by Annie De Groot | Sep 9, 2019EpiVax_PANDA_Taspoglutide_April_19_Final
Predicting Immunogenicity of Peptide Drugs and Their Impurities Using in Silico Tools: Taspoglutide Case Study by Annie De Groot | May 15, 2019EpiVax_TaspoglutidePoster_14May19